Polychromatic flow cytometry is a powerful tool in measuring and quantitating the expression of numerous antigens present on a single cell. Different instrument configurations or instruments with ...
Flow cytometry has become a key analytical technique in clinical trials. Through its multiparametric analysis, single-cell resolution, and high-throughput evaluation capabilities, flow cytometry can ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE-IVD certification for the BD FACSDuet™ automated flow cytometry system. The new ...
Flow cytometry remains an essential tool for cell analysis. Although often relegated to specialized core facilities, flow cytometry instruments are in fact becoming increasingly commonplace in life ...
FRANKLIN LAKES, N.J. & SAN DIEGO--(BUSINESS WIRE)-- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation ...
Our staff are here to aid in use of a wide array of cytometers. We consult at every step of the process, including panel design, and marker and color choice, as well as data analysis and ...
With flow cytometry, as with many technologies that enjoy continuous use, we can see an evolution of capabilities. Spectral analysis, image capture, and artificial intelligence are just a few of the ...
Scientists use multicolor flow cytometry to identify and characterize targeted cellular subpopulations by using multiple fluorescent markers. The technology has seen rapid advancements in recent years ...
Flow-based methods allow researchers to collect multiparameter data from individual cells in their samples, but the fate of samples depends on the instrument. In addition to cell analysis, cell ...
The MarketWatch News Department was not involved in the creation of this content. CHICAGO, June 11, 2024 /PRNewswire/ -- The global flow cytometry market, valued at $5.1 billion in 2024, is primed for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results